Pfizer has opened new facilities at its site in Louvain-la-Neuve. The multinational pharmaceutical company has dedicated 22 million to expanding the factory and laboratory of veterinary medicine.
The new laboratory, which is already operational, was designed to develop new vaccines, analyze the results of clinical trials and develop test procedures. The research and development center will come on line at the end of the year, once the authorities conduct the qualification procedure.
With these new facilities, Pfizer Animal Health intends to quicken its response time if a new infectious disease emerges that afflicts animals, and particularly livestock. The company will be able to develop and produce large quantities of vaccines at its research center in the event of a pandemic caused by an emerging disease.
The Pfizer site in Louvain-la-Neuve employs 220 people, and the center’s expansion has already created 13 new positions.
The inauguration ceremony was attended by the Regional Prime Minster of Wallonia, Rudy Demotte, and all of the managers praised the Region’s valuable assistance in making such investments possible.
RTBF – 10/11/2012